Loss of life expectancy due to colorectal cancer at national and subnational level in China, 2005-2020: a retrospective population-based study from China national mortality surveillance system

IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES The Lancet Regional Health: Western Pacific Pub Date : 2025-02-01 DOI:10.1016/j.lanwpc.2024.101338
Fanshu Yan, Zhe Liu, Peng Yin
{"title":"Loss of life expectancy due to colorectal cancer at national and subnational level in China, 2005-2020: a retrospective population-based study from China national mortality surveillance system","authors":"Fanshu Yan,&nbsp;Zhe Liu,&nbsp;Peng Yin","doi":"10.1016/j.lanwpc.2024.101338","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Colorectal cancer was the fourth leading cause of cancer death in China in 2020, and mortality due to colorectal cancer increased in economically developed regions between 2005 and 2020. This study aimed to explore the temporal trends in loss of life expectancy due to colorectal cancer in China and all mainland provinces from 2005 to 2020.</div></div><div><h3>Methods</h3><div>The mortality data were obtained from the China National Mortality Surveillance System (NMSS), which covers a population of more than 300 million people in 31 provincial-level administrations with provincial-level representativeness. Under-reporting rate was used to adjust for death rates from all cause and colorectal cancer. The demographic data were obtained from the National Bureau of Statistic. We used the abbreviated life table method to calculate life expectancy. Loss of life expectancy due to colorectal cancer was calculated as the life expectancy after excluding colorectal cancer deaths in the whole population by gender and provinces. Underlying cause of death coded as colorectal cancer based on the International Classification of Diseases, 10th edition (ICD-10) was used (C18.0-C18.9). The study was approved by the Ethics Committee of The National Center for Chronic and Noncommunicable Disease Control and Prevention.</div></div><div><h3>Findings</h3><div>The loss of life expectancy due to colorectal cancer in China in 2020 was 0.15 years, slightly higher in men (0.154 years) than in women (0.147 years). Loss of life expectancy due to colorectal cancer is on an increasing trend between 2005 and 2020, for both genders, with a higher increase for men (0.03) than for women (0.02). The provinces with the highest loss of life expectancy due to colorectal cancer in 2020 were Beijing (0.30), Zhejiang (0.26), and Shanghai (0.26), and the lowest were Tibet (0.04), Hebei (0.09), and Henan (0.10). Among all 31 mainland provinces, 3 provinces (Hebei, Henan and Jiangxi) showed a decreasing trend for loss of life expectancy due to colorectal cancer. For the remaining provinces, Tianjin (96.97%), Fujian 80.28%), and Beijing (70.28%) had the highest increase in loss of life expectancy due to colorectal cancer during the study period.</div></div><div><h3>Interpretation</h3><div>The loss of life expectancy due to colorectal cancer is increasing during 2005-2020, indicating it remains a major public health problem in China, particularly in economically developed provinces. The strengths of this study are the use of loss of life expectancy as the indicator to measure the burden caused by colorectal cancer and its temporal trend based on nationwide data. The limitation of this study is that we were unable to analyze the associated factors for the variations between different provinces.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"55 ","pages":"Article 101338"},"PeriodicalIF":7.6000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Regional Health: Western Pacific","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666606524003328","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Colorectal cancer was the fourth leading cause of cancer death in China in 2020, and mortality due to colorectal cancer increased in economically developed regions between 2005 and 2020. This study aimed to explore the temporal trends in loss of life expectancy due to colorectal cancer in China and all mainland provinces from 2005 to 2020.

Methods

The mortality data were obtained from the China National Mortality Surveillance System (NMSS), which covers a population of more than 300 million people in 31 provincial-level administrations with provincial-level representativeness. Under-reporting rate was used to adjust for death rates from all cause and colorectal cancer. The demographic data were obtained from the National Bureau of Statistic. We used the abbreviated life table method to calculate life expectancy. Loss of life expectancy due to colorectal cancer was calculated as the life expectancy after excluding colorectal cancer deaths in the whole population by gender and provinces. Underlying cause of death coded as colorectal cancer based on the International Classification of Diseases, 10th edition (ICD-10) was used (C18.0-C18.9). The study was approved by the Ethics Committee of The National Center for Chronic and Noncommunicable Disease Control and Prevention.

Findings

The loss of life expectancy due to colorectal cancer in China in 2020 was 0.15 years, slightly higher in men (0.154 years) than in women (0.147 years). Loss of life expectancy due to colorectal cancer is on an increasing trend between 2005 and 2020, for both genders, with a higher increase for men (0.03) than for women (0.02). The provinces with the highest loss of life expectancy due to colorectal cancer in 2020 were Beijing (0.30), Zhejiang (0.26), and Shanghai (0.26), and the lowest were Tibet (0.04), Hebei (0.09), and Henan (0.10). Among all 31 mainland provinces, 3 provinces (Hebei, Henan and Jiangxi) showed a decreasing trend for loss of life expectancy due to colorectal cancer. For the remaining provinces, Tianjin (96.97%), Fujian 80.28%), and Beijing (70.28%) had the highest increase in loss of life expectancy due to colorectal cancer during the study period.

Interpretation

The loss of life expectancy due to colorectal cancer is increasing during 2005-2020, indicating it remains a major public health problem in China, particularly in economically developed provinces. The strengths of this study are the use of loss of life expectancy as the indicator to measure the burden caused by colorectal cancer and its temporal trend based on nationwide data. The limitation of this study is that we were unable to analyze the associated factors for the variations between different provinces.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
The Lancet Regional Health: Western Pacific
The Lancet Regional Health: Western Pacific Medicine-Pediatrics, Perinatology and Child Health
CiteScore
8.80
自引率
2.80%
发文量
305
审稿时长
11 weeks
期刊介绍: The Lancet Regional Health – Western Pacific, a gold open access journal, is an integral part of The Lancet's global initiative advocating for healthcare quality and access worldwide. It aims to advance clinical practice and health policy in the Western Pacific region, contributing to enhanced health outcomes. The journal publishes high-quality original research shedding light on clinical practice and health policy in the region. It also includes reviews, commentaries, and opinion pieces covering diverse regional health topics, such as infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, aging health, mental health, the health workforce and systems, and health policy.
期刊最新文献
Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling study Strategies for the prevention of ischemic stroke in atrial fibrillation in East Asia: clinical features, changes and challenges Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients Middle-age cerebral small vessel disease and cognitive function in later life: a population-based prospective cohort study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1